No Data
No Data
Express News | Ensysce Biosciences Inc -Ensysce Biosciences Regains Compliance With Nasdaq
12 Health Care Stocks Moving In Thursday's Pre-Market Session
GainersOneMedNet (NASDAQ:ONMD) shares moved upwards by 103.2% to $1.0 during Thursday's pre-market session. The company's market cap stands at $23.7 million. iSpecimen (NASDAQ:ISPC) stock moved upward
Sector Update: Health Care
Health care stocks fell late Monday afternoon with the NYSE Health Care Index down 0.1% and the Health Care Select Sector SPDR Fund (XLV) shedding 0.2%. The iShares Biotechnology ETF (IBB) rose 0.5%.
Ensysce Biosciences Renews Collaboration With Quotient Sciences for Pain Killer Drug Study
Ensysce Biosciences (ENSC) said Monday it renewed the collaboration with Quotient Sciences to undertake a study to evaluate examine and evaluate the full commercial dose range of PF614-MPAR. The phase
Ensysce Biosciences Continues Collaboration to Advance the Clinical Development of Innovative Overdose Protection Platform
Ensysce Biosciences, Inc. (NASDAQ:ENSC) ("Ensysce" or the "Company"), a clinical stage pharmaceutical company developing innovative solutions for severe pain relief while reducing the potential for opioid abuse and overdose, today announced the renewal of its collaboration with Quotient Sciences to undertake the study PF614-MPAR-102 to examine and evaluate the full commercial dose range of the PF614-MPAR drug product.
10-Q: Quarterly report
No Data